Investing.com - Cardlytics (NASDAQ: CDLX) reported first quarter EPS of $-0.56, $0.10 worse than the analyst estimate of $-0.47. Revenue for the quarter came in at $67.61M versus the consensus estimate of $66.46M.
Cardlytics's stock price closed at $14.60. It is up 131.01% in the last 3 months and up 153.91% in the last 12 months.
Cardlytics saw 3 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Cardlytics's stock price’s past reactions to earnings here.
According to InvestingPro, Cardlytics's Financial Health score is "fair performance".
Check out Cardlytics's recent earnings performance, and Cardlytics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar